rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Stephen M. Bloch

Director

Company insider

Files Form 4 as: Director, Liquidia; Director, Liquidia Technologies; Director, Marinus Pharmaceuticals; 10% owner, Active Network; Director, Amicus Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
368
Buys
2
Sells
113
Bought
$13.0M
Sold
$439.3M
Companies
5
Companies where not an officer
5
First trade
5 Jun 2007
Last trade
5 Oct 2026
Last filed
7 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LQDA LiquidiaDirector · Biotechnology · last 5 Oct 20260 buys · 20 sells
Liquidia TechnologiesDirector · last 22 Jun 20201 buy · 0 sells
Marinus PharmaceuticalsDirector · last 28 Sep 20151 buy · 0 sells
Active Network10% owner · last 1 Mar 20120 buys · 2 sells
Amicus TherapeuticsDirector · last 11 Feb 20090 buys · 91 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
100Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Oct 2026filed 7 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$6.4M235,477 at $27.13filing
23 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$8.6M96,400 at $89.44filing
23 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$327K3,600 at $90.71filing
23 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$8.6M96,400 at $89.44filing
23 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$327K3,600 at $90.71filing
22 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$3.3M37,406 at $87.70filing
22 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$4.3M48,032 at $88.65filing
22 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.3M14,562 at $89.24filing
22 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$3.3M37,406 at $87.70filing
22 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$4.3M48,032 at $88.65filing
22 Jul 2026filed 24 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.3M14,562 at $89.24filing
21 Jul 2026filed 22 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$6.0M74,444 at $79.98filing
21 Jul 2026filed 22 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$45K556 at $80.66filing
21 Jul 2026filed 22 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$6.0M74,444 at $79.98filing
21 Jul 2026filed 22 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$45K556 at $80.66filing
20 Jul 2026filed 22 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$286K3,596 at $79.55filing
20 Jul 2026filed 22 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$286K3,596 at $79.55filing
7 Jul 2026filed 8 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.8M22,718 at $80.48filing
7 Jul 2026filed 8 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$2.2M27,282 at $81.31filing
7 Jul 2026filed 8 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$1.8M22,718 at $80.48filing

Sectors

Health Care20
Not placed95

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Rajeev SaggarChief Medical Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days